Updates to the Newfoundland and Labrador Provincial Drug Schedules have taken place to reflect changes by NAPRA to their Natural Health Products (NHPs) policy.
The National Drug Schedules (NDS) were developed before Health Canada began regulating the sale of NHPs in Canada. When NHP regulations came into force in 2004, many products included in the NDS became reclassified as NHPs. Since NHPs are beyond the scope of NAPRA’s NDS, NAPRA has decided to remove NHPs currently listed within the NDS in a stepwise, risk-based approach. See NAPRA’s full explanation.
Changes are as follows:
1) Effective January 2, 2020: NHPs currently listed within the Unscheduled category and within Schedule III will be removed from the NDS.
2) Effective January 2, 2022: NHPs currently listed within Schedules I and II will be removed from the NDS.
As of 2022, all products with a Natural Product Number (NPN) or Drug Identification Number-Homeopathic Medicine (DIN-HM) from Health Canada will be considered outside the scope of NAPRA’s National Drug Schedules.
Please see the Provincial Drug Schedules page for more information.